A growing number of funding agencies now require that research articles they have funded must be made open access. This may be either by mandating deposit in repositories after an embargo period or by stipulating that research is published as open access.
Publishing in Kidney Cancer complies with all major funding agency requirements.
Green Open Access Publishing (Self-Archiving)
Authors may self-archive and post the final manuscript version on their own institution, company or funding agency repositories immediately upon acceptance. Authors that are funded by the NIH, Research Councils UK (RCUK) and Wellcome Trust are welcome to deposit their final manuscript version to PubMed Central (Submission Method C) and Europe PubMed Central immediately upon acceptance. In all cases a publication reference and URL to the journal’s website must be provided on the first page of the manuscript.
Alternatively, the author can submit the final published pdf version of the article, which can be ordered from IOS Press. This service costs €100/US$120 and an order form will be sent with the galley proof of the article to the corresponding author. Ordered PDFs will be sent to the author after final publication of the article in an issue. IOS Press holds to no embargo period after final publication. Orders for a PDF of published articles can also be sent to firstname.lastname@example.org.
Gold Open Access Publishing (Open Access Option)
The Kidney Cancer open access option helps authors to comply with major funder mandates. This option allows authors the choice of paying a fee to make their article publicly available on the journal’s website immediately upon publication. Authors may deposit the published version of their open access article into PubMed Central (Submission Method C) and other repositories immediately upon publication. All open access articles are published under the terms of the Creative Commons Attribution Non-Commercial License.
If requested by the author, Research Councils UK (RCUK) and Wellcome Trust funded open access articles will be published under the terms of the Creative Commons Attribution License (CC-BY). After acceptance of their article, the author can select open access publishing and should send a separate message to the publisher at email@example.com to notify that their article (include reference number) should be published open access under the RCUK mandate.
All other open access articles are published under the terms of the Creative Commons Attribution Non-Commercial License (CC-BY-NC).